Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer

The results demonstrate that the NLR at the time of VTE diagnosis could be a useful biomarker for predicting the response and prognosis following anticoagulation in patients with lung cancer and VTE.